Immunomedics (IMMU) Misses Q1 EPS by 3c
Get instant alerts when news breaks on your stocks. Claim your 2-week free trial to StreetInsider Premium here.
Immunomedics (NASDAQ: IMMU) reported Q1 EPS of ($0.17), $0.03 worse than the analyst estimate of ($0.14). Revenue for the quarter came in at $129.2 thousand versus the consensus estimate of $3.1 million.
For earnings history and earnings-related data on Immunomedics (IMMU) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Steelcase (SCS) Reports Preliminary Q3 EPS In-Line with Views, Revs Light
- Xactly Corporation (XTLY) Tops Q3 EPS by 7c
- Layne Christensen (LAYN) Misses Q3 EPS by 6c
Create E-mail Alert Related CategoriesEarnings
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!